Hikma Pharmaceuticals Plc Director/PDMR Shareholding (7303P)
May 30 2018 - 9:20AM
UK Regulatory
TIDMHIK
RNS Number : 7303P
Hikma Pharmaceuticals Plc
30 May 2018
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name Sigurdur Olafsson
--- --------------------- -----------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Chief Executive Officer
--- --------------------- -----------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- -----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ----------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- -----------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- -----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ----------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- -----------------------------------
b) Nature of Market purchase of 20,000 Ordinary
the transaction Shares by Landsbankinn for and on
behalf of Sigurdur Olafsson.
--- --------------------- -----------------------------------
c) Price(s) and Price(s): GBP13.0919
volume(s) Volume(s): 20,000
--- --------------------- -----------------------------------
d) Aggregated
information 20,000
* Volume GBP261,838.00
* Price
--- --------------------- -----------------------------------
e) Date of the 30 May 2018
transaction
--- --------------------- -----------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- -----------------------------------
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBSGDUIBXBGIG
(END) Dow Jones Newswires
May 30, 2018 10:20 ET (14:20 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024